vNARs as Neutralizing Intracellular Therapeutic Agents: Glioblastoma as a Target

Autor: Alejandro Manzanares-Guzmán, Pavel H. Lugo-Fabres, Tanya A. Camacho-Villegas

Publikováno v: Antibodies, Vol 13, Iss 1, p 25 (2024)

Glioblastoma is the most prevalent and fatal form of primary brain tumors. New targeted therapeutic strategies for this type of tumor are imperative given the dire prognosis for glioblastoma patients and the poor results of current multimodal therapy

Externí odkaz: https://doaj.org/article/23591c975aaf41b4b52eeadca6135dee

Atherosclerosis is Reduced by Using an Inhibition of DNA Methylation Strategy Based on Protein Nanoparticles

Autor: Dannia Colín-Castelán, Gloria Barbosa-Sabanero, Alejandro Manzanares-Guzman, Gertrud Lund, Enrique Ramírez-Chávez, Ramon Carriles-Jaimes, Ana C. Marquez-Sanchez, Lino Sánchez-Segura, Agustino Martínez-Antonio, Silvio Zaina, Dalia Rodríguez-Ríos, Jorge Molina-Torres, Yolanda Alvarado-Caudillo

Publikováno v: American Heart Journal. 229:157-158

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8c492479b88c77bead1530623afad3e9
https://doi.org/10.1016/j.ahj.2020.10.005

Tissue compatibility of SN-38-loaded anticancer nanofiber matrices

Autor: Francesc Cano, Carles Monterrubio, Gaia Botteri, Alejandro Sosnik, Jaume Mora, Manuel Vázquez-Carrera, Helena Castillo-Ecija, Laura Garcia-Alvarez, Camilo A. Restrepo-Perdomo, Mariona Suñol, José Antonio Tornero, Alejandro Manzanares, Angel M. Carcaboso, Guillem Pascual-Pasto, Bonaventura Ruiz

Publikováno v: UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
Recercat. Dipósit de la Recerca de Catalunya
instname
ADVANCED HEALTHCARE MATERIALS
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Advanced healthcare materials
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Dipòsit Digital de la UB
Universidad de Barcelona

Delivery of chemotherapy in the surgical bed has shown preclinical activity to control cancer progression upon subtotal resection of pediatric solid tumors, but whether this new treatment is safe for tumor-adjacent healthy tissues remains unknown. He

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d570cf640822129908c319957a64809
http://hdl.handle.net/2117/122234

Prognostic value of patient‐derived xenograft engraftment in pediatric sarcomas

Autor: Helena Castillo-Ecija, Ofelia Cruz, Nagore G. Olaciregui, Alejandro Manzanares, Ana Jimenez-Cabaco, Guillem Pascual-Pasto, Alicia Castañeda, Noelia Salvador, Merce Baulenas-Farres, Leire Balaguer-Lluna, Oscar Muñoz-Aznar, Victor Burgueño, Angel M. Carcaboso, Ferran Torner, Francisco J Vicario, Lucas Krauel, Carles Monterrubio, Jaume Mora, Moira Garraus, Monica Vila-Ubach, Veronica Celis, Claudia Resa-Pares, Rosalia Carrasco, Maite Gorostegui, Andres Morales La Madrid, Sara Perez-Jaume, Vicente Santa-Maria, Mariona Suñol, Cinzia Lavarino, Margarita Vancells, Maria Cuadrado-Vilanova

Publikováno v: The Journal of Pathology: Clinical Research
The Journal of Pathology: Clinical Research, Vol 7, Iss 4, Pp 338-349 (2021)
Journal of Pathology – clinical research

The goals of this work were to identify factors favoring patient‐derived xenograft (PDX) engraftment and study the association between PDX engraftment and prognosis in pediatric patients with Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma. We us

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c55f7420ec3b9f349beb56dc5c620d3